Jia Fu

2.3k citations
58 papers · 1.6k indexed · h-index 20
Topics
Chronic Kidney Disease and Diabetes (17 papers)Renal Diseases and Glomerulopathies (17 papers)Cancer-related molecular mechanisms research (4 papers)

In The Last Decade

Jia Fu

52 papers receiving 1.6k citations

Peers

Jia Fu
Comparison fields: 5 of 106
  • Nephrology 702
  • Molecular Biology 653
  • Immunology 313
  • Cancer Research 181
  • Epidemiology 151
Replace Takahisa Kawakami with:
Takahisa Kawakami Japan
Gábor Kökény Hungary
Kohei Uchimura Japan
Jean‐François Cailhier Canada
Shinya Kaname Japan
Chiara Barisione Italy
Jia Fu relative to Takahisa Kawakami Japan Takahisa Kawakami's profile →
Citations per field
00.5×4.8×
Takahisa Kawakami · 1×
Citations per year

Countries citing papers authored by Jia Fu

Since Specialization
Citations

This map shows the geographic impact of Jia Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Fu more than expected).

Fields of papers citing papers by Jia Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Fu. The network helps show where Jia Fu may publish in the future.

Co-authorship network of co-authors of Jia Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Jia Fu. A scholar is included among the top collaborators of Jia Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia Fu. Jia Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 6
5 4
6 1
7 11
8 7
9 55
10 10
11 9
12 18
13 65
14 26
15 151
16 9
17 35
18 37
19
The mechanism of the mixture of Apostichopus japonicus and Cordyceps militaris on protection of renal injury in diabetic rats
1
20
Experimental studies of immunological effect of splenic autograft on tumor-bearing rats
0

About Jia Fu

Jia Fu is a scholar working on Nephrology, Cancer Research and Human Factors and Ergonomics, having authored 58 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (17 papers), Renal Diseases and Glomerulopathies (17 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Nephrology (702 citations), Immunology (313 citations) and Cancer Research (181 citations). Jia Fu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include John Cijiang He, Kyung Lee, Peter Y. Chuang, Zhihong Liu, Detlef Schlöndorff, Zeguo Sun, Weijia Zhang, Chengguo Wei, Vivette D. D’Agati and Kemal M. Akat. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and PLANT PHYSIOLOGY.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026